Overview
U.S. sodium bicarbonate producer's Q4 net sales grew 3.9%, meeting analyst expectations
Adjusted EPS for Q4 beat analyst expectations
Company completed divestiture of vitamin business, impacting organic sales growth
Outlook
Company expects 2026 organic sales growth of approximately 3% to 4%
Church & Dwight anticipates 2026 adjusted EPS growth of 5% to 8%
Company forecasts 2026 adjusted gross margin expansion of approximately 100 basis points
Result Drivers
VITAMIN BUSINESS EXIT - The exit from the vitamin business impacted organic sales growth, limiting it to 0.7% for the quarter
PRODUCTIVITY PROGRAMS - Gross margin expansion driven by productivity programs, higher volumes, and favorable mix
MARKETING INVESTMENTS - Incremental marketing investments contributed to adjusted EPS growth of 11.7%
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Sales
Meet
$1.64 bln
$1.64 bln (14 Analysts)
Q4 Adjusted EPS
Beat
$0.86
$0.84 (16 Analysts)
Q4 EPS
$0.60
Q4 Net Income
$143.50 mln
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy", 8 "hold" and 4 "sell" or "strong sell"
The average consensus recommendation for the household products peer group is "buy"
Wall Street's median 12-month price target for Church & Dwight Co Inc is $100.00, about 8.7% above its January 29 closing price of $91.96
The stock recently traded at 25 times the next 12-month earnings vs. a P/E of 24 three months ago
Press Release: ID:nBw1Fz6GQa
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)